Source Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$362K Buy
3,185
+101
+3% +$12K 0.11% 84
2024
Q2
$382K Buy
3,084
+1
+0% +$129 0.12% 78
2024
Q1
$407K Buy
3,083
+73
+2% +$9K 0.12% 81
2023
Q4
$328K Buy
3,010
+168
+6% +$17.4K 0.1% 97
2023
Q3
$293K Sell
2,842
-131
-4% -$14.1K 0.1% 104
2023
Q2
$343K Buy
2,973
+187
+7% +$21.2K 0.11% 100
2023
Q1
$296K Buy
2,786
+165
+6% +$17.8K 0.1% 101
2022
Q4
$291K Buy
2,621
+72
+3% +$7.36K 0.11% 102
2022
Q3
$219K Buy
2,549
+277
+12% +$24.7K 0.09% 107
2022
Q2
$207K Buy
+2,272
New +$201K 0.08% 109

Other funds holding MRK

Source Financial Advisors's MRK Position: Q3 2024 in Review

Source Financial Advisors increased its Merck (MRK) stake by 3.3% in Q3 2024, buying an estimated $12K and bringing the position to 3,185 shares worth $362K. The position accounts for 0.11% of the portfolio, ranked #84.

Source Financial Advisors first reported a position in MRK in Q2 2022 and has held it in 10 quarters since. The position peaked at $407K in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Source Financial Advisors held 3,185 shares of Merck worth $362K as of Q3 2024.
  • Source Financial Advisors bought 101 Merck shares in Q3 2024, an estimated $12K.
  • Merck made up 0.11% of Source Financial Advisors's portfolio in Q3 2024, its #84 holding.
  • Source Financial Advisors first reported a position in Merck in Q2 2022 and has held it in 10 quarters since.
  • Source Financial Advisors's Merck position peaked at $407K in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Source Financial Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.